Summary Straumann Holding AG (Straumann) develops dental implants and devices. Straumann's product portfolio includes dental implants, active surfaces, prosthetic components, digital solutions such as intra-oral scanning, and CADCAM, bone substitutes, and regenerative membranes. The company categorizes its solutions under three groups: tooth replacement solutions, restorative solutions and regenerative solutions. Its products find applications in tooth replacement and restoration solutions or prevention of tooth loss. It also offers a wide range of customized services including practice building tools, business building initiatives, customer hotline. The company markets and sells its solutions and services directly to dental professionals through its subsidiaries and distribution partners in Europe, North America, Asia-Pacific and other regions throughout the world. Straumann is headquartered in Basel, Switzerland. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Straumann Holding AG - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 6 Straumann Holding AG Company Snapshot 7 Straumann Holding AG Company Overview 7 Straumann Holding AG Pipeline Products and Clinical Trials Overview 8 Straumann Holding AG- Pipeline Analysis Overview 10 Business Description 10 Key Facts 11 Straumann Holding AG - Major Products and Services 12 Straumann Holding AG Pipeline Products by Development Stage 14 Straumann Holding AG Clinical Trials by Trial Status 16 Straumann Holding AG Pipeline Products Overview 18 Abutment Blanks 18 Abutment Blanks Product Overview 18 CARES 9 19 CARES 9 Product Overview 19 CARES In-Lab Scanner 20 CARES In-Lab Scanner Product Overview 20 CARES Visual 10 21 CARES Visual 10 Product Overview 21 Enhanced Bone Graft 22 Enhanced Bone Graft Product Overview 22 Hygiene Cassette 23 Hygiene Cassette Product Overview 23 Integrated Workflow 24 Integrated Workflow Product Overview 24 Less Invasive Implant 25 Less Invasive Implant Product Overview 25 New Materials For Restoration 26 New Materials For Restoration Product Overview 26 ProArch For Full Arch Restoration 27 ProArch For Full Arch Restoration Product Overview 27 Smaller Diameter Implant 28 Smaller Diameter Implant Product Overview 28 Soft Tissue Control Implant 29 Soft Tissue Control Implant Product Overview 29 Straumann Bone Level Tapered Implant 30 Straumann Bone Level Tapered Implant Product Overview 30 Straumann Bone Level Tapered Implant Clinical Trial 31 Straumann CARES Restorations With 3M ESPE Lava Plus 32 Straumann CARES Restorations With 3M ESPE Lava Plus Product Overview 32 Straumann CARES X-Stream For Bars And Bridges 33 Straumann CARES X-Stream For Bars And Bridges Product Overview 33 Straumann Novaloc 34 Straumann Novaloc Product Overview 34 Straumann Variobase Prosthesis For Bar/Bridge 35 Straumann Variobase Prosthesis For Bar/Bridge Product Overview 35 Straumann Holding AG - Key Competitors 36 Straumann Holding AG - Key Employees 37 Straumann Holding AG - Key Employee Biographies 38 Straumann Holding AG - Locations And Subsidiaries 39 Head Office 39 Other Locations & Subsidiaries 39 Recent Developments 42 Straumann Holding AG, Recent Developments 42 May 23, 2016: Straumann Announces Change In Board Of Directors And Compensation Committee 42 May 03, 2016: Straumann reports strong start to the year with organic revenue growth of 12% in Q1 42 May 03, 2016: Straumann Emdogain launched in new wound-healing indication 43 Apr 22, 2016: Straumann introduces Lifetime Guarantee Plus for Roxolid implants 44 Feb 25, 2016: Straumann And Anthogyr Announce Partnership 44 Dec 03, 2015: Straumann Announces Leadership Changes To Strengthen Momentum In Europe And North America 44 Oct 29, 2015: Straumann On Track With Organic Growth Of 9% In First 9 Months 45 Aug 20, 2015: Straumann Reports Organic Growth Of 9% In First Half Of 2015 With Further Profitability Improvements 47 Mar 27, 2015: Petra Rumpf joins Executive Management Board as Head of Instradent & Strategic Alliances 50 Mar 09, 2015: Straumann partners with Amann Girrbach to enter inlab milling segment 51 Appendix 52 Methodology 52 About GlobalData 52 Contact Us 52 Disclaimer 52
List of Tables
Straumann Holding AG Pipeline Products and Clinical Trials Overview 8 Straumann Holding AG Pipeline Products by Equipment Type 8 Straumann Holding AG Pipeline Products by Indication 9 Straumann Holding AG Clinical Trials by Trial Status 9 Straumann Holding AG, Key Facts 11 Straumann Holding AG, Major Products and Services 12 Straumann Holding AG Number of Pipeline Products by Development Stage 14 Straumann Holding AG Pipeline Products Summary by Development Stage 15 Straumann Holding AG Clinical Trials by Trial Status 16 Straumann Holding AG Clinical Trials Summary 17 Abutment Blanks - Product Status 18 Abutment Blanks - Product Description 18 CARES 9 - Product Status 19 CARES 9 - Product Description 19 CARES In-Lab Scanner - Product Status 20 CARES In-Lab Scanner - Product Description 20 CARES Visual 10 - Product Status 21 CARES Visual 10 - Product Description 21 Enhanced Bone Graft - Product Status 22 Enhanced Bone Graft - Product Description 22 Hygiene Cassette - Product Status 23 Hygiene Cassette - Product Description 23 Integrated Workflow - Product Status 24 Integrated Workflow - Product Description 24 Less Invasive Implant - Product Status 25 Less Invasive Implant - Product Description 25 New Materials For Restoration - Product Status 26 New Materials For Restoration - Product Description 26 ProArch For Full Arch Restoration - Product Status 27 ProArch For Full Arch Restoration - Product Description 27 Smaller Diameter Implant - Product Status 28 Smaller Diameter Implant - Product Description 28 Soft Tissue Control Implant - Product Status 29 Soft Tissue Control Implant - Product Description 29 Straumann Bone Level Tapered Implant - Product Status 30 Straumann Bone Level Tapered Implant - Product Description 30 Straumann Bone Level Tapered Implant - A Multi-center, Prospective, Single Cohort, Post-market Clinical Follow-up (PMCF) Study to Assess Implant Survival After Insertion of Straumann Bone Level Tapered (BLT) Implant o 2.9 mm in the Clinical Practice Setting 31 Straumann Bone Level Tapered Implant - Immediate Placement of the Straumann Bone Level Tapered Implant with Early Loading in Single Tooth Gaps in the Maxilla and Mandible Compared to Delayed Placement 31 Straumann CARES Restorations With 3M ESPE Lava Plus - Product Status 32 Straumann CARES Restorations With 3M ESPE Lava Plus - Product Description 32 Straumann CARES X-Stream For Bars And Bridges - Product Status 33 Straumann CARES X-Stream For Bars And Bridges - Product Description 33 Straumann Novaloc - Product Status 34 Straumann Novaloc - Product Description 34 Straumann Variobase Prosthesis For Bar/Bridge - Product Status 35 Straumann Variobase Prosthesis For Bar/Bridge - Product Description 35 Straumann Holding AG, Key Employees 37 Straumann Holding AG, Key Employee Biographies 38 Straumann Holding AG, Subsidiaries 39
List of Figures
Straumann Holding AG Pipeline Products by Equipment Type 9 Straumann Holding AG Pipeline Products by Development Stage 14 Straumann Holding AG Clinical Trials by Trial Status 16
Global Bio polyethylene terephthalate (PET) market size is likely to be valued at USD 12.6 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing preference of biopolymers in numerous applications coupled with favorable goverRead More...
Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commercRead More...
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from mainRead More...
Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to moRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.